Funding Rounds
NorthSea Therapeutics Series A (2017, $27M)
NorthSea TherapeuticsInnovative therapeutic drugs to treat inflammatory, metabolic and liver diseases.
Summary
Stage: Series A
Raised Amount: $27.00M
Raised Date: 2017-12-01
Stage: Series A
Raised Amount: $27.00M
Raised Date: 2017-12-01
